Kang, Jin Hyun
Lee, Seung Ho
Lee, Jawon
Choi, Murim
Cho, Junhun
Kim, Seok Jin
Kim, Won Seog
Ko, Young Hyeh
Yoo, Hae Yong
Funding for this research was provided by:
Ministry of Health and Welfare (HI14C2331, HI14C3414)
National Research Foundation of Korea (NRF-2018R1D1A1B07043696)
Article History
Received: 18 May 2020
Accepted: 11 January 2021
First Online: 19 January 2021
Ethics approval and consent to participate
: The present study was approved by the Institutional Review Board in accordance with the Samsung Medical Center under the title “Identification of targeted therapeutic markers for malignant lymphoma (IRB No: 2015-01-034-001)”. All patients provided written informed consent prior to study participation.
: Not applicable.
: The authors declare that they have no competing interests.